Proteomic analyses of human plasma: Venus versus Mars
- 31 August 2011
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 52 (2), 417-424
- https://doi.org/10.1111/j.1537-2995.2011.03316.x
Abstract
BACKGROUND: Plasma is vital for the resuscitation of injured patients and to restore necessary procoagulants, especially Factors (F)II, FV, FVII, FX, and FXIII; however, female plasma has been implicated in the majority of transfusion‐related acute lung injury (TRALI) cases and male‐only plasma transfusion regimens have significantly decreased the incidence of TRALI. Little is known about the human plasma proteome, and no comparisons have been made between male and female plasma; therefore, we hypothesize that there are significant differences between plasma from male and female donors. STUDY DESIGN AND METHODS: Five units of fresh‐frozen plasma each were collected from nulliparous female donors and male donors, and the proteome was analyzed by depleting the 14 most common proteins by immunoaffinity columns followed by protein separation by one dimension gel electrophoresis, tryptic digestion of the proteins, analysis of the peptides by liquid chromatography–tandem mass spectrometry, and identification employing human protein sequence databases. RESULTS: Female plasma versus male plasma contained pregnancy zone protein (419‐ to 580‐fold), FV (twofold), α1‐antitrypsin (twofold), β2‐microglobulin (twofold), and Complement Factors H and C4B (1.5‐ to 2‐fold) at significantly higher concentrations than males and males contained significant increases in Fc‐binding protein (twofold), protein Z–dependent protease inhibitor (twofold), phosphatidylinositol glycan–specific phospholipase (fourfold), protein S‐100 (threefold), and transgelin‐2 (14‐fold) versus females (p < 0.005). The increases in FV, α1‐antitrypsin, and β2‐microglobulin were confirmed by an activity assay or immunoblots. CONCLUSION: We conclude that there are proteomic differences between male and female plasma, which could be exploited to improve clinical outcomes in transfused patients.Keywords
This publication has 50 references indexed in Scilit:
- Ovarian Cancer Biomarker Performance in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial SpecimensCancer Prevention Research, 2011
- Effective reduction of transfusion‐related acute lung injury risk with male‐predominant plasma strategy in the American Red Cross (2006‐2008)Transfusion, 2010
- Survival Prediction for Pancreatic Cancer Patients Receiving Gemcitabine TreatmentMolecular & Cellular Proteomics, 2010
- Activation of native TRPC1/C5/C6 channels by endothelin‐1 is mediated by both PIP3 and PIP2 in rabbit coronary artery myocytesJournal Of Physiology-London, 2009
- Tissue Proteomics Reveals Differential and Compartment-Specific Expression of the Homologs Transgelin and Transgelin-2 in Lung Adenocarcinoma and Its StromaJournal of Proteome Research, 2009
- PROGRESS IN UREMIC TOXIN RESEARCH: Beta2‐MicroglobulinSeminars in Dialysis, 2009
- Serpins in thrombosis, hemostasis and fibrinolysisJournal of Thrombosis and Haemostasis, 2007
- The impact of universal leukodepletion of the blood supply on hemovigilance reports of posttransfusion purpura and transfusion‐associated graft‐versus‐host diseaseTransfusion, 2007
- Temporal changes of the plasma levels of cystatin C, β‐trace protein, β2‐microglobulin, urate and creatinine during pregnancy indicate continuous alterations in the renal filtration processScandinavian Journal of Clinical and Laboratory Investigation, 2007
- Structures of bacterial immunoglobulin-binding domains and their complexes with immunoglobulinsCurrent Opinion in Structural Biology, 1995